Cigarette smoke condensate activates nuclear transcription factor-κB through phosphorylation and degradation of IκBα: Correlation with induction of cyclooxygenase-2

Carcinogenesis

Volumn 23, Issue 9, 2002, Pages 1511-1518

  Anto, Ruby John ^a   Mukhopadhyay, Asok ^a   Shishodia, Shishir ^a   Gairola, C Gary ^b   Aggarwal, Bharat B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b University of Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE CONDENSATE; CYCLOOXYGENASE 2; GENE PRODUCT; I KAPPA B KINASE; PHOSPHOTRANSFERASE; PROTEIN INHIBITOR; SERINE; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CARCINOGENESIS; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ASSAY; ENZYME INDUCTION; GENE EXPRESSION; HISTIOCYTIC LYMPHOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; KINETICS; LEUKEMIA CELL LINE; LUNG ALVEOLUS CELL; LYMPHOMA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REPORTER GENE; SQUAMOUS CELL; T LYMPHOCYTE;

CYCLOOXYGENASE 2; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; GENE EXPRESSION; GENES, REPORTER; HELA CELLS; HUMANS; I-KAPPA B KINASE; I-KAPPA B PROTEINS; ISOENZYMES; MEMBRANE PROTEINS; NF-KAPPA B; PHOSPHORYLATION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN SUBUNITS; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; SMOKING; TIME FACTORS; TNF RECEPTOR-ASSOCIATED FACTOR 2; TUMOR CELLS, CULTURED; U937 CELLS;

EID: 0036714882     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Cancer in developing countries
2. Annual report to the nation on the status of cancer 1973-1996 with a special section on lung cancer and tobacco smoking
3. The less harmful cigarette: A controversial issue. A tribute to Ernst L. Wynder
4. Tobacco smoke carcinogens and lung cancer
5. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53
6. A tobacco-specific N-nitrosamine or cigarette smoke condensate causes neoplastic transformation of xenotransplanted human bronchial epithelial cells
7. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses
8. Phosphorylation meets ubiquitination: The control of NF-κB activity
9. Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity which is required for cellular transformation
10. Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells
11. Activators and target genes of Rel/NF-κB transcription factors
12. MAP3K-related kinase involved in NF-kappaB induction by TNF CD95 and IL-1
13. Activation of NF-κB by RANK requires TRAF6 and NF-κB-inducing kinase (NIK): Identification ofa novel TRAF6 interaction motif
14. Comparison of aliquot and complete sample procedure for the determination of nicotine in cigarette smoke
15. Assay for redox-sensitive transcription factors
16. Interferon-α suppresses activation of nuclear transcription factors NF-κB and AP-1 and potentiates TNF-induced apoptosis
17. NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules
18. Distinct signal transduction pathways mediate nuclear factor-κB induction by IL-1 beta in epithelial and lymphoid cells
19. Role of the protein kinase C lambda/iota isoform in nuclear factor-kappaB activation by interleukin-1beta or tumor necrosis factor-alpha: Cell type specificities
20. The PTEN tumor suppressor protein inhibits tumor necrosis factor-induced nuclear factor kappa B activity
21. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B
22. Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms
23. Oxidative stress induces NF-kappaB nuclear translocation without degradation of IkappaBalpha
24. IkappaB alpha degradation is not a requirement for the X-ray-induced activation of nuclear factor kappaB in normal rat astrocytes and human brain tumour cells
25. Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor kappaB independently of IkappaB degradation
26. Tyrosine phosphorylation of 1 kappa B-alpha activates NF-kappa B without proteolytic degradation of 1 kappa B-alpha
27. Phosphorylation of human 1 kappa B-alpha on serines 32 and 36 controls 1 kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli
28. Pervanadate-induced nuclear factor-κB activation requires tyrosine phosphorylation and degradation of IkB a: Comparison with tumor necrosis factor-α
29. Crucial role of the amino-terminal tyrosine residue 42 and the carboxyl-terminal PEST domain of 1 kappa B alpha in NF-kappa B activation by an oxidative stress
30. Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases
31. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis
32. Differential IkappaB kinase activation and IkappaBalpha degradation by interleukin-1beta and tumor necrosis factor-alpha in human U937 monocytic cells. Evidence for additional regulatory steps in kappaB-dependent transcription
33. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways
34. The alpha and beta subunits of IkappaB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF
35. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex
36. The tobacco chemists' research conference: A half century of advances in analytical methodology of tobacco and its products
37. Spin trapping of nitric acid in aqueous solutions of cigarette smoke
38. Fractionation of aqueous cigarette tar extracts: Fractions that contain the tar radical cause DNA damage
39. Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity
40. An international literature survey of 'IARC Group I carcinogens' reported in mainstream cigarette smoke
41. Tobacco smoke carcinogens and lung cancer
42. Lung tumorigenicity of NNK given orally to A/J mice: Its application to chemopreventive efficacy studies
43. Quantitative analysis of the hydrogen peroxide formed in equeous cigarette tar extracts
44. Free radical pathology: Inactivation of human alpha-1-proteinase inhibitor by products from the reaction of nitrogen dioxide with hydrogen peroxide and the etiology of emphysema
45. Benzo[a]pyrene activates the human p53 gene through induction of nuclear factor kappaB activity
46. Benzo[a]pyrene induces the transcription of cyclooxygenase-2 in vascular smooth muscle cells. Evidence for the involvement of extracellular signal-regulated kinase and NF-κB
47. The activity of NF-kappaB in Swiss 3T3 cells exposed to aqueous extracts of cigarette smoke is dependent on thioredoxin
48. RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis
49. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal
50. The essential role of MEKK3 in TNF-induced NF-kappaB activation
51. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines
52. Mechanism of cigarette smoke condensate induced adhesion of human monocytes to cultured endothelial cells
53. Cigarette smoke condensate-induced adhesion molecule expression and transendothelial migration of monocytes
54. Cyclooxygenase-2 and carcinogenesis
55. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas
56. Chemoprevention of breast cancer in rats by celecoxib a cyclooxygenase 2 inhibitor
57. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
58. Correlation of expression of cyclooxygenase-2 vascular endothelial growth factor and peroxisome proliferator-activated receptor delta with head and neck squamous cell carcinoma
59. Inhalation toxicity studies on cigarette smoke. IV. Expression of the dose of smoke particulate material to the lungs of experimental animals
60. The role of nuclear factor-kappa B activation in airway inflammation following adenovirus infection and COPD
61. Correlation between nuclear factor-kappaB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma
62. Nuclear factor-kappaB transcription factor decoy treatment inhibits graft coronary artery disease after cardiac transplantation in rodents
63. The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation
64. Early activation of transcription factor NF-kappaB during ischemia in perfused rat heart
65. In vivo transfection of cis element 'decoy' against nuclear factor-kappaB binding site prevents myocardial infarction
66. A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy' against NFkappaB binding site: Evidence for a role of NFkappaB in ischemia-reperfusion injury